Close Menu

NEW YORK (GenomeWeb) – Thermo Fisher Scientific has launched a program by which it will collaborate with partners to develop its next-generation sequencing-based Oncomine portfolio of products into clinical tests that can be used as companion diagnostics. The Institute of Medical Genetics and Pathology at University Hospital Basel, Switzerland will be the first partner in the initiative, dubbed the Next Generation Companion Dx Center of Excellence Program.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Apr
30
Sponsored by
Lexogen

This webinar will discuss novel long-read transcript sequencing (LRTseq) methods for transcriptome annotation that could increase the efficiency and accuracy of future sequencing projects.

May
08
Sponsored by
Sysmex Inostics

This webinar will present recent evidence that demonstrates how incorporating circulating tumor DNA (ctDNA) assessments into real-world patient management can influence patient care decisions, alter radiographic interpretations, and impact clinical outcomes.

May
15
Sponsored by
Thermo Fisher Scientific

This webinar will discuss how Radboud University Medical Center’s Department of Human Genetics is using exon-level copy number variant (CNV) detection by microarray to assist its efforts in constitutional genome testing. 

May
16
Sponsored by
PerkinElmer

This webinar will discuss a comprehensive end-to-end workflow for soil metagenomic shotgun sequencing that offers an unbiased alternative to amplicon-based approaches to assess the composition of culture-free microbial communities and predict functional profiles.